California to manufacture and produce its own insulin as Congress debates $35 monthly cap
As the Senate debates capping out-of-pocket insulin costs at $35 per month, California is moving forward with its plans to take matters into its own hands.
Gov. Gavin Newsom set aside $100 million in the state budget for the manufacture of its insulin, with the hopes of making it more affordable for residents of the state. According to the budget, the insulin that will eventually be developed and manufactured will be a low-cost biosimilar insulin product.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.